CELLDEX THERAPEUTICS INC NEW - COM (CLDX)

CUSIP: 15117B103

Q3 2018 13F Holders as of 30 Sep 2018

Type / Class
Equity / COM
Total 13F shares
47,915,892
Share change
-6,432,021
Total reported value
$21,609,810
Put/Call ratio
162%
Price per share
$0.45
Number of holders
77
Value change
-$3,127,821
Number of buys
24
Number of sells
45

Quarterly Holders Quick Answers

What is CUSIP 15117B103?
CUSIP 15117B103 identifies CLDX - CELLDEX THERAPEUTICS INC NEW - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CELLDEX THERAPEUTICS INC NEW - COM (CLDX) as of Q3 2018

As of 30 Sep 2018, CELLDEX THERAPEUTICS INC NEW - COM (CLDX) was held by 77 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 47,915,892 shares. The largest 10 holders included KLP Enterprises, LLC, Meditor Group Ltd, Vanguard Group Inc, RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., DIMENSIONAL FUND ADVISORS LP, DEUTSCHE BANK AG\, MILLENNIUM MANAGEMENT LLC, TWO SIGMA INVESTMENTS, LP, and GSA CAPITAL PARTNERS LLP. This page lists 77 institutional shareholders reporting positions in this security for the Q3 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.